Navigation Links
Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October
Date:7/23/2008

bability of success, the interim analysis provides us with the potential to accelerate our BLA amendment for PROVENGE," said Mitchell H. Gold, president and chief executive officer of Dendreon.

If the IDMC reports in October that the pre-specified criterion for statistical significance is not met, then the company anticipates continuing the trial with the expectation of reporting final results in the second half of 2009.

About IMPACT Study Design

The IMPACT trial is a multicenter, randomized, double-blind, placebo- controlled Phase 3 study, which enrolled just over 500 men with metastatic, androgen independent prostate cancer with a primary endpoint of overall survival. Dendreon is conducting the IMPACT trial under a Special Protocol Assessment (SPA) agreed upon with the FDA.

About Prostate Cancer

Prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than one million men in the United States have prostate cancer, with an estimated 186,320 new cases expected to be diagnosed in 2008, and approximately 28,660 men expected to die this year from the disease. Currently there are limited treatment options for men with advanced, metastatic prostate cancer.

About Active Cellular Immunotherapy with PROVENGE

PROVENGE may represent the first product in a new class of active cellular immunotherapies (ACIs) that are uniquely designed to use live human cells to engage the patient's own immune system with the goal of eliciting a specific long-lasting response against cancer. Active cellular immunotherapy holds promise because it may provide patients with a meaningful clinical benefit, such as survival, combined with low toxicity.

About Dendreon

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics. The Company applies its experti
'/>"/>

SOURCE Dendreon Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Dendreon Completes Target Enrollment of 500 Patients in Phase 3 IMPACT Study of Provenge(R) For Advanced Prostate Cancer
3. Dendreon Presents Data Correlating the Cumulative Potency of PROVENGE(R) to Overall Survival
4. Dendreon Presents Preclinical Data Demonstrating Activity of Trp-p8 agonist, D-3263, in Benign Prostatic Hyperplasia
5. Dendreon Initiates Phase 2 Trial of PROVENGE in Patients With Localized Prostate Cancer Prior to Surgery
6. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
7. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
8. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
9. Interim Safety Data Favorable for Vicals Phase 2 Trial of DNA Vaccine Against CMV
10. Interim Phase 2 Data for Exelixis XL880 Show Anti-Tumor Activity in Papillary Renal Cell Cancer
11. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... , May 28, 2015  According to Kalorama ... acquire Omnicare for approximately $12.7 billion fits a prevailing ... benefit from an aging population. The U.S. long term ... expected to continue as the aging population increases demand ... services. The healthcare market researcher,s report, The Long ...
(Date:5/28/2015)... 2015  Caris Life Sciences®, a leading biotechnology ... medicine, today announced the presentation of data from ... of Caris Molecular Intelligence®, the company,s panomic comprehensive ... resistance and pathway alterations in solid tumors. The ... at the annual meeting of the American Society ...
(Date:5/27/2015)... DUBLIN , May 27, 2015 /PRNewswire/ ... ) has announced the addition of the  ...   report to their offering.  ... provides a worldwide strategic overview of the ... regions, market segments and product categories. , ...
Breaking Medicine Technology:Kalorama: CVS Purchase of Omnicare Fits the Long Term Care Trend 2Kalorama: CVS Purchase of Omnicare Fits the Long Term Care Trend 3Kalorama: CVS Purchase of Omnicare Fits the Long Term Care Trend 4Caris Life Sciences Presents Large Cohort Biomarker Analyses that Characterizes Drug Resistances and Pathway Aberrations to Inform Targeted Anticancer Treatment Strategies 2Caris Life Sciences Presents Large Cohort Biomarker Analyses that Characterizes Drug Resistances and Pathway Aberrations to Inform Targeted Anticancer Treatment Strategies 3Caris Life Sciences Presents Large Cohort Biomarker Analyses that Characterizes Drug Resistances and Pathway Aberrations to Inform Targeted Anticancer Treatment Strategies 4Caris Life Sciences Presents Large Cohort Biomarker Analyses that Characterizes Drug Resistances and Pathway Aberrations to Inform Targeted Anticancer Treatment Strategies 5Global Orthopedics Market Strategies 2015 2
... 2011 The Coalition for Ethical Imaging (CEI), a ... practices in Texas, is supporting House Bill 1809, sponsored ... that will help rein in healthcare costs in the ... includes radiologists and other medical professionals, members of the ...
... Snow Jr., chairman and chief executive officer, Medco Health Solutions, ... the Citi 2011 Global Health Care Conference in New York ... The presentation at the Hilton, New York, will begin ... officer, is also scheduled to attend. The presentation ...
Cached Medicine Technology:Coalition for Ethical Imaging Advocates Diagnostic Imaging Reform in the 82nd Texas Legislature 2Coalition for Ethical Imaging Advocates Diagnostic Imaging Reform in the 82nd Texas Legislature 3Medco to Present at the Citi 2011 Global Health Care Conference 2
(Date:5/27/2015)... May 28, 2015 Calls Upon Individuals, Organizations ... A new nationwide initiative – a “Summer of Service” – ... and build partnerships to grow the number of individuals and ... its commitment to Veterans by inviting the community to visit ... June 29, 2015 from 1 – 3:00 p.m. in the ...
(Date:5/27/2015)... San Rafael, CA (PRWEB) May 27, 2015 ... Softball Camp director, Bree Nasti, the Adelphi University softball ... to the Divsion II Softball Championship since becoming a ... at 0-11, Adelphi University softball team turned it around ... Softball Championship. After defeating University of Central Missouri in ...
(Date:5/27/2015)... Down is a reputable source of 2015 NHL Western Conference ... middle of their series against the Anaheim Ducks with the Ducks ... can win tonight at home, this will tie up the series ... Honda Center in Anaheim. , During the regular season, the ... they won the Pacific Division by 8 points ahead of the ...
(Date:5/27/2015)... As the U.S. Supreme Court considers the ... the Affordable Care Act (ACA), an investigation by the ... RAND Corporation and Express Scripts provides an unprecedented look ... enrollees. , The analysis is published online as ... also appear in the journal’s June issue. , The ...
(Date:5/27/2015)... 2015 Khanna Vision Institute (KVI) announced the ... focussed on keratoconus eye disease . Keratoconus is commonly ... its onset in the teenage years. It worsens over the ... front clear part of the eye is defective. It becomes ... It results in poor vision which cannot even be corrected ...
Breaking Medicine News(10 mins):Health News:VA Begins “Summer of Service” to Bolster Volunteer Assistance for Veterans 2Health News:VA Begins “Summer of Service” to Bolster Volunteer Assistance for Veterans 3Health News:US Sports Camps and Nike Softball Camps Congratulate the Adelphi University Softball Team 2Health News:Blackhawks vs. Ducks NHL Western Conference Finals Tickets: Ticket Down Slashes Ticket Prices on Chicago Blackhawks vs. Anaheim Ducks 2015 NHL Western Conference Finals 2Health News:Large-Scale Analysis of Medication Data Provides Insights into Who Is Covered by Affordable Care Act 2Health News:Large-Scale Analysis of Medication Data Provides Insights into Who Is Covered by Affordable Care Act 3Health News:Large-Scale Analysis of Medication Data Provides Insights into Who Is Covered by Affordable Care Act 4Health News:KVI announced the launch of The Keratoconus website focused on age based keratoconus treatment . 2
... (HealthDay News) -- Hormone levels at certain phases of the ... Researchers used MRI to study the brains of women ... pleasant, unpleasant or neutral. This test was repeated at different ... follicular stage of the menstrual cycle, no areas of the ...
... Reporter , TUESDAY, Oct. 26 (HealthDay News) -- Dr. Alexander Heazell ... their first child in 2001. They planned to name him Jack. ... wife,s blood pressure had shot up during the pregnancy, and at ... Losing the baby was devastating for Heazell and his wife. The ...
... and biologist Professor Cesare Montecucco, 62, of the Department ... has won the 100,000 euro Paul Ehrlich and Ludwig ... the field of bacterial diseases, including tetanus, botulism, anthrax ... by the Scientific Board of the Paul Ehrlich Foundation. ...
... scar tissue surrounding cancer tumours aims to provide new targets for ... deaths in the UK. Funded by the UK charity Pancreatic ... family of molecules present in this scar tissue - known as ... tumour growth. The project is led by surgeon and ...
... are common among the caregivers of children with a ... of a small study from the Johns Hopkins Children Center. ... researchers add. The study,s findings, published online in ... healthcare staff to do a better job in educating parents, ...
... (HealthDay News) -- Having a prostate-specific antigen (PSA) test to ... develops it will spread to other parts of the body, ... debate on whether PSA screenings actually improve survival rates or, ... that routine screening not only improves the patient,s quality of ...
Cached Medicine News:Health News:Stillbirth Can Be Devastating, Unpredictable 2Health News:Stillbirth Can Be Devastating, Unpredictable 3Health News:Professor Cesare Montecucco to receive the 2011 Paul Ehrlich and Ludwig Darmstaedter Prize 2Health News:Stroma may provide key to better cancer treatment 2Health News:Knowledge gaps, fears common among parents of children with drug-resistant bacteria 2Health News:Knowledge gaps, fears common among parents of children with drug-resistant bacteria 3Health News:PSA Test Reduces Risk of Spread if Prostate Cancer Strikes 2Health News:PSA Test Reduces Risk of Spread if Prostate Cancer Strikes 3
Sinskey lens manipulator, straight. Also available in titanium....
ICL manipulator with textured micro-ball tip....
... Keeler ophthalmoscopes are individually adjusted for perfect ... eye, not on paper. This, along with ... focus, ensures that whatever the patient's pupil ... largest field of view. Lithium-ion technology provides ...
The Beta 200S combines Heine's patented aspherical optics (U.S. Pat. 4.963.014) and a single-step Rekoss disk with a range of 36 to +38 dpt. to provide perfectly-focused images even in cases of high ...
Medicine Products: